Gelteq Ltd key statistics and ratios

In fiscal 2025, Gelteq Ltd had return on equity of -37.7%, an operating margin of -3317.7%, debt equal to 26.7% of equity and a current ratio of 0.27. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Gelteq Ltd: financial ratios, annual
Fiscal year	2023Jun 2023	2025Jun 2025
Gross margin	—	30.3%
Operating margin	<−999%	<−999%
Net margin	<−999%	<−999%
Free-cash-flow margin	<−999%	<−999%
Return on equity	−19.0%	−37.7%
Return on assets	−15.7%	−29.6%
Asset turnover	0.00	0.01
Current ratio	0.73	0.27
Debt to equity	13.3%	26.7%
Interest cover (operating income ÷ interest)	n/m	n/m
R&D as % of revenue	832.9%	379.5%
Capital spending as % of revenue	43.2%	1.9%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

2 of 6 checks passed · June 30, 2025

What it owns · $14m

Short-term assets $1mLonger-term assets $13m

What it owes, and who funded it · $14m

Short-term liabilities $4mLonger-term liabilities $0mShareholders' equity $10m

Short-term assets cover short-term liabilities $990,334 of assets due within a year against $4m of liabilities due within a year.
Short-term assets cover long-term liabilities $990,334 short-term assets against $25,334 of longer-dated liabilities.
More cash than debt $226,537 of cash against $3m of debt.
Debt below 40% of shareholders' equity Debt is 27% of equity.
Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
A year's operating cash flow covers at least 20% of debt −$4m of operating cash flow against $3m of debt.
Operating profit covers interest at least five times over Operating income of −$4m against $1m of interest.

From Gelteq Ltd's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: AKAN vs GELS GELS vs PRFX GELS vs SCNX

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Gelteq Ltd's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Gelteq Ltd.